Hot Pursuit     05-Jul-24
Glenmark Pharmaceuticals Ltd spurts 3.8%, rises for third straight session
Glenmark Pharmaceuticals Ltd is quoting at Rs 1344.75, up 3.8% on the day as on 12:49 IST on the NSE. The stock is up 101.23% in last one year as compared to a 24.53% gain in NIFTY and a 47.56% gain in the Nifty Pharma index.

Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 1344.75, up 3.8% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.09% on the day, quoting at 24279.9. The Sensex is at 79810.25, down 0.3%. Glenmark Pharmaceuticals Ltd has added around 11.15% in last one month.

Meanwhile, Nifty Pharma index of which Glenmark Pharmaceuticals Ltd is a constituent, has added around 6.43% in last one month and is currently quoting at 20192.6, up 1.37% on the day. The volume in the stock stood at 8.95 lakh shares today, compared to the daily average of 6.89 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 1348.5, up 3.78% on the day. Glenmark Pharmaceuticals Ltd is up 101.23% in last one year as compared to a 24.53% gain in NIFTY and a 47.56% gain in the Nifty Pharma index.

The PE of the stock is 25.66 based on TTM earnings ending March 24.

Previous News
  Glenmark Pharmaceuticals allots 12,653 equity shares under ESOP
 ( Corporate News - 17-Apr-25   20:08 )
  Glenmark Pharma’s US arm set to launch generic Adderall tablets
 ( Hot Pursuit - 17-Apr-25   08:04 )
  Glenmark USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
 ( Corporate News - 16-Apr-25   19:53 )
  Glenmark Pharmaceuticals Ltd slips for fifth straight session
 ( Hot Pursuit - 11-Apr-25   13:35 )
  Glenmark Pharmaceuticals announces change in senior management
 ( Corporate News - 07-Apr-25   09:00 )
  Glenmark launches Vancomycin Hydrochloride for injection USP in the USA
 ( Hot Pursuit - 01-Apr-25   10:31 )
  Glenmark Pharmaceuticals launches Vancomycin Hydrochloride for Injection USP
 ( Corporate News - 01-Apr-25   09:40 )
  Nifty trades above 23,250 mark; realty shares climb
 ( Market Commentary - Mid-Session 21-Mar-25   10:36 )
  Glenmark Pharma gains as arm gets USFDA nod for Olopatadine Ophthalmic solution
 ( Hot Pursuit - 21-Mar-25   09:49 )
  Glenmark Pharmaceuticals launches Empagliflozin in India
 ( Corporate News - 12-Mar-25   13:29 )
  Glenmark Pharma launches generic Empagliflozin in India
 ( Hot Pursuit - 12-Mar-25   11:38 )
Other Stories
  Tata Technologies Q4 PAT climbs 12% QoQ to Rs 189 cr
  25-Apr-25   17:34
  VST Inds slides after Q4 PAT slumps 42% YoY to Rs 67 cr; declares dividend of Rs 10/sh
  25-Apr-25   15:45
  Atul gains after Q4 PAT soars 117% YoY; declares dividend of Rs 25/sh
  25-Apr-25   15:20
  Orient Electric Q4 PAT soars 144% YoY to Rs 31 crore
  25-Apr-25   15:20
  Oriental Hotels PAT rises 8% YoY in Q4 FY25
  25-Apr-25   15:05
  Maruti Suzuki records PAT of Rs 3,711.1 crore in Q4; Op. EBIT margin at 8.7%
  25-Apr-25   15:00
  VST Industries Ltd leads losers in 'A' group
  25-Apr-25   15:00
  SRM Contractors Ltd leads losers in 'B' group
  25-Apr-25   14:45
  Chennai Petro rises after Q4 PAT skyrockets to Rs 470 crore; declares dividend of Rs 5/sh
  25-Apr-25   14:44
  Volumes soar at Indian Energy Exchange Ltd counter
  25-Apr-25   14:30
Back Top